PacBio hires pair of Illumina vets; plus Ionis, Sana, Purespring, eFFECTOR, Constellation, T2, MiNA, Vividion, Pharma Two B and WIB

Pacific Biosciences of California Inc. (NASDAQ:PACB) filled two newly created posts via the hiring of a pair of Illumina Inc. (NASDAQ:ILMN) veterans: Mark Van Oene as COO and Peter Fromen as chief commercial officer. Van Oene was Illumina’s SVP and chief commercial officer, and Fromen was most recently global VP of population genomics and precision health.

Ionis Pharmaceuticals Inc. (NASDAQ:IONS) promoted Eugene Schneider to EVP and chief clinical development officer from SVP. Schneider, a seven-year veteran of the company, will oversee clinical development of antisense therapies across all of Ionis’ therapeutic franchises. ...